Page last updated: 2024-08-23

pirfenidone and Mesothelioma

pirfenidone has been researched along with Mesothelioma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Joensuu, E; Koli, K; Li, C; Myllärniemi, M; Rezov, V; Rönty, M; Vartiainen, V; Yin, M	1

Other Studies

1 other study(ies) available for pirfenidone and Mesothelioma

Article	Year
Pirfenidone decreases mesothelioma cell proliferation and migration via inhibition of ERK and AKT and regulates mesothelioma tumor microenvironment in vivo. Scientific reports, 2018, 07-03, Volume: 8, Issue:1 Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Collagen; Extracellular Matrix; Female; Fibroblasts; Fibrosis; Humans; Lung Neoplasms; MAP Kinase Signaling System; Mesothelioma; Mesothelioma, Malignant; Mice; Mice, Inbred BALB C; Proto-Oncogene Proteins c-akt; Pyridones; Signal Transduction; Tumor Microenvironment; Xenograft Model Antitumor Assays	2018

Article

Year

Pirfenidone decreases mesothelioma cell proliferation and migration via inhibition of ERK and AKT and regulates mesothelioma tumor microenvironment in vivo.

Scientific reports, 2018, 07-03, Volume: 8, Issue:1

Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Collagen; Extracellular Matrix; Female; Fibroblasts; Fibrosis; Humans; Lung Neoplasms; MAP Kinase Signaling System; Mesothelioma; Mesothelioma, Malignant; Mice; Mice, Inbred BALB C; Proto-Oncogene Proteins c-akt; Pyridones; Signal Transduction; Tumor Microenvironment; Xenograft Model Antitumor Assays

2018